CITIGROUP INC - ASCENDIS PHARMA A/S ownership

ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 26 filers reported holding ASCENDIS PHARMA A/S in Q1 2016. The put-call ratio across all filers is - and the average weighting 1.2%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of ASCENDIS PHARMA A/S
ValueSharesWeighting
Q3 2023$10,223,334
+54.1%
109,177
+46.9%
0.01%
+166.7%
Q2 2023$6,633,061
-26.1%
74,320
-11.2%
0.00%
-57.1%
Q1 2023$8,973,027
+9.4%
83,688
+24.6%
0.01%
+16.7%
Q4 2022$8,204,082
+6115.2%
67,175
+5152.2%
0.01%
Q3 2022$132,000
-11.4%
1,279
-19.9%
0.00%
Q2 2022$149,000
-33.2%
1,597
-16.1%
0.00%
Q1 2022$223,000
-32.0%
1,903
-21.9%
0.00%
Q4 2021$328,000
-42.0%
2,437
-31.3%
0.00%
Q3 2021$566,000
+14.8%
3,548
-5.3%
0.00%
Q2 2021$493,000
+185.0%
3,748
+179.7%
0.00%
Q1 2021$173,000
-44.6%
1,340
-28.4%
0.00%
Q4 2020$312,000
-26.9%
1,871
-32.4%
0.00%
Q3 2020$427,000
-10.9%
2,769
-14.6%
0.00%
Q2 2020$479,000
+51.1%
3,241
+15.0%
0.00%
Q1 2020$317,000
-36.0%
2,819
-20.7%
0.00%
Q4 2019$495,000
+326.7%
3,555
+196.0%
0.00%
Q3 2019$116,000
-4.1%
1,201
+14.7%
0.00%
Q2 2019$121,000
+72.9%
1,047
+76.6%
0.00%
Q1 2019$70,000
+677.8%
593
+317.6%
0.00%
Q1 2018$9,000
-78.6%
142
-86.4%
0.00%
Q4 2017$42,000
+4100.0%
1,044
+1988.0%
0.00%
Q1 2016$1,0000.0%50
+19.0%
0.00%
Q2 2015$1,0000.0%42
-47.5%
0.00%
Q1 2015$1,000800.00%
Other shareholders
ASCENDIS PHARMA A/S shareholders Q1 2016
NameSharesValueWeighting ↓
RA Capital Management 5,865,338$978,221,00013.68%
Vivo Capital, LLC 1,797,745$299,828,00013.38%
Sofinnova Investments, Inc. 1,109,874$185,105,00011.02%
Avoro Capital Advisors LLC 1,800,000$300,204,0005.17%
Eventide Asset Management 1,704,148$284,218,0004.36%
Stenahm Asset Managment Ltd 29,000$4,837,0004.07%
Ghost Tree Capital, LLC 105,000$17,512,0003.90%
Eversept Partners, LP 187,043$31,195,0323.66%
Spyglass Capital Management LLC 701,594$117,012,0003.59%
Q Global Advisors, LLC 23,183$3,866,0002.72%
View complete list of ASCENDIS PHARMA A/S shareholders